AirDuo RespiClick (Fluticasone/Salmeterol) for COPD | MyCOPDTeam

Connect with others who understand.

sign up Log in
About MyCOPDTeam
Powered By

AirDuo RespiClick is a prescription drug approved by the Food and Drug Administration (FDA) to treat asthma in people age 12 years and older. AirDuo RespiClick may be prescribed off-label in cases of chronic obstructive pulmonary disease (COPD). AirDuo RespiClick is a combination drug composed of Fluticasone and Salmeterol.

Fluticasone is a glucocorticoid steroid, a drug that suppresses the immune system. Fluticasone is believed to work by reducing inflammation in the lungs, lowering the risk of bronchospasm. Salmeterol is a long-acting bronchodilator (LABA), a drug that dilates the bronchi and bronchioles in the lungs, making it easier to breathe. Salmeterol is believed to work by relaxing smooth muscles in the airways.

How do I take it?
AirDuo RespiClick is generally taken twice daily by oral inhalation.

AirDuo RespiClick comes in the form of an inhaler containing powder.

Side effects
The FDA-approved label for AirDuo RespiClick lists common side effects including headache, cold symptoms, cough, oral yeast infection (thrush), and back pain.

Rare but serious side effects listed for AirDuo RespiClick include increased risk for worsening infections, paradoxical bronchospasm (bronchospasm caused by taking medication), hypercorticism and adrenal suppression (hormonal imbalance), and asthma-related hospitalization and death.

For more details about this treatment, visit:

AirDuo RespiClick – Teva Respiratory

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in